Pharmacists in Lajas, Puerto Rico


11 Pharmacists found in Lajas
female pharmacist

Ada V Millan


Pharmacist
65 Infanteria No 2 Sur, Lajas, PR 00667
787-899-2270     787-899-2270

female pharmacist

Aida Esther Santiago


Pharmacist
Farmacia San Pablo Y San Pedro, 152 Calle Union, Lajas, PR 00667
939-214-7205     847-396-2748

male pharmacist

Eric Joel Jusino Belen


Pharmacist
3700 Carr 116 # 101, Lajas, PR 00667
787-899-8719    



female pharmacist

Glendalis Vargas, PHARM D


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
Carr 116 Km 0.5, Lajas, PR 00667
787-808-1585    

female pharmacist

Dr. Katiana Nicole Castillo-camareno


Pharmacist
Carr 116 Int. Carr 304 Km 0.1 La Parguera, Lajas, PR 00667
787-899-8719    

female pharmacist

Marisol Lebron, PHARMD


Pharmacist
Carr 116 Int Carr 304 Km 0.1, Lajas, PR 00667
787-923-7178    

female pharmacist

Mrs. Nilka Lopez Torres, LCDA


Pharmacist
Bo Palmarejo Carr 101 Km 7.1, Migrant Halth Center, Inc., Lajas, PR 00667
787-808-3509     787-808-0897

male pharmacist

Mr. Pedro Garcia, PHARMACIST


Pharmacist
Carr 304 Ave Los Pescadores, La Parguera, Lajas, PR 00667
787-899-8719    

female pharmacist

Rusdaly Caraballo Orengo, PHARMD


Pharmacist
Carr. 315 Km 1.0 Ave. Flamboyanes, Interseccion Ave. 65 De Infanteria, Lajas, PR 00667
787-254-8151     787-899-2097

female pharmacist

Mrs. Wilda G Santana, RPH


Pharmacist
Hc-o2, Box14850, Lajas, PR 00667
787-808-3509    

female pharmacist

Yarimar Vargas


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
Hc 1 Box 7576, Lajas, PR 00667
787-509-0944    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.